Literature DB >> 18561951

Colonic vascular conductance increased by Daikenchuto via calcitonin gene-related peptide and receptor-activity modifying protein 1.

Toru Kono1, Takashi Koseki, Shinichi Chiba, Yoshiaki Ebisawa, Naoyuki Chisato, Jun Iwamoto, Shinichi Kasai.   

Abstract

BACKGROUND: Daikencyuto (DKT) is a traditional Japanese medicine (Kampo) and is a mixture of extract powders from dried Japanese pepper, processed ginger, ginseng radix, and maltose powder and has been used as the treatment of paralytic ileus. DKT may increase gastrointestinal motility by an up-regulation of the calcitonin gene-related peptide (CGRP). CGRP is also the most powerful vasoactive substance. In the present study, we investigated whether DKT has any effect on the colonic blood flow in rats.
MATERIALS AND METHODS: Experiments were performed on fasted anesthetized and artificially ventilated Wistar rats. Systemic mean arterial blood pressure and heart rate were recorded. Red blood cell flux in colonic blood flow was measured using noncontact laser tissue blood flowmetry, and colonic vascular conductance (CVC) was calculated as the ratio of flux to mean arterial blood pressure. We examined four key physiological mechanisms underlying the response using blocker drugs: CGRP1 receptor blocker (CGRP(8-37)), nitric oxide synthase inhibitor, vasoactive intestinal polypeptide (VIP) receptor blocker ([4-Cl-DPhe6, Leu17]-VIP), and substance P receptor blocker (spantide). Reverse transcription-polymerase chain reaction was used for the detection of mRNA of calcitonin receptor-like receptor, receptor-activity modifying protein 1, the component of CGRP 1 receptor and CGRP. After laparotomy, a cannula was inserted into the proximal colon to administer the DKT and to measure CVC at the distal colon.
RESULTS: Intracolonal administration of DKT (10, 100, and 300 mg/kg) increased CVC (basal CVC, 0.10 mL/mmHg) from the first 15-min observation period (0.14, 0.17, and 0.17 mL/mmHg, respectively) and with peak response at either 45 min (0.17 mL/mmHg by 10 mg/kg), or 75 and 60 min (0.23 and 0.21 mL/mmHg by 100 and 300 mg/kg, respectively). CGRP(8-37) completely abolished the DKT-induced hyperemia, whereas nitric oxide synthase inhibitor partially attenuated the DKT-induced hyperemia. [4-Cl-DPhe6, Leu17]-VIP and spantide did not affect the hyperemia. Japanese pepper significantly increased CVC at 45 min or later, whereas ginseng radix only showed a significant increase at 15 min. Reverse transcription-polymerase chain reaction showed that mRNA for calcitonin receptor-like receptor, receptor-activity modifying protein 1, and CGRP were expressed in rat colon and up-regulated by DKT.
CONCLUSIONS: The present study demonstrated that DKT increased CVC, which was mainly mediated by CGRP and its receptor components.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18561951     DOI: 10.1016/j.jss.2008.02.057

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  31 in total

1.  Kampo medicine "Dai-kenchu-to" prevents CPT-11-induced small-intestinal injury in rats.

Authors:  Motoya Chikakiyo; Mitsuo Shimada; Toshihiro Nakao; Jun Higashijima; Kozo Yoshikawa; Masanori Nishioka; Takashi Iwata; Nobuhiro Kurita
Journal:  Surg Today       Date:  2011-11-10       Impact factor: 2.549

2.  Anticancer effect of a Kampo preparation Daikenchuto.

Authors:  Takuya Nagata; Kazufumi Toume; Lv Xiao Long; Katsuhisa Hirano; Toru Watanabe; Shinichi Sekine; Tomoyuki Okumura; Katsuko Komatsu; Kazuhiro Tsukada
Journal:  J Nat Med       Date:  2016-04-08       Impact factor: 2.343

3.  The effect of Daikenchuto on postoperative intestinal motility in patients with right-side colon cancer.

Authors:  Takeshi Yamada; Satoshi Matsumoto; Michihiro Koizumi Akihisa Matsuda; Seiichi Shinji; Yasuyuki Yokoyama; Goro Takahashi; Takuma Iwai; Kouki Takeda; Keiichiro Ohta; Eiji Uchida
Journal:  Surg Today       Date:  2016-11-21       Impact factor: 2.549

4.  Daikenchuto (TU-100) ameliorates colon microvascular dysfunction via endogenous adrenomedullin in Crohn's disease rat model.

Authors:  Toru Kono; Yuji Omiya; Yoshiki Hira; Atsushi Kaneko; Shinichi Chiba; Tatsuya Suzuki; Masamichi Noguchi; Tsuyoshi Watanabe
Journal:  J Gastroenterol       Date:  2011-08-02       Impact factor: 7.527

5.  Efficacy of daikenchuto, a traditional Japanese Kampo medicine, for postoperative intestinal dysfunction in patients with gastrointestinal cancers: meta-analysis.

Authors:  Masayoshi Hosaka; Ichiro Arai; Yoshihisa Ishiura; Tomohiro Ito; Yoshinobu Seki; Tateaki Naito; Yuko Masuzawa; Takeo Nakayama; Yoshiharu Motoo
Journal:  Int J Clin Oncol       Date:  2019-07-12       Impact factor: 3.402

6.  Epithelial transient receptor potential ankyrin 1 (TRPA1)-dependent adrenomedullin upregulates blood flow in rat small intestine.

Authors:  Toru Kono; Atsushi Kaneko; Yuji Omiya; Katsuya Ohbuchi; Nagisa Ohno; Masahiro Yamamoto
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-12-28       Impact factor: 4.052

7.  The effect of traditional Japanese medicine (Kampo) on gastrointestinal function.

Authors:  Erito Mochiki; Mitsuhiro Yanai; Tetsuro Ohno; Hiroyuki Kuwano
Journal:  Surg Today       Date:  2010-11-26       Impact factor: 2.549

8.  Clinical pharmacology of daikenchuto assessed by transit analysis using radiopaque markers in patients with colon cancer undergoing open surgery: a multicenter double-blind randomized placebo-controlled study (JFMC39-0902 additional study).

Authors:  Hidetoshi Katsuno; Koutarou Maeda; Masatoshi Ohya; Kazuhiko Yoshioka; Akira Tsunoda; Keiji Koda; Hiroyoshi Matsuoka; Hiroki Ohge; Satoshi Morita; Shigetoyo Saji; Takashi Kanematsu; Masaki Kitajima
Journal:  J Gastroenterol       Date:  2015-07-11       Impact factor: 7.527

9.  Localization of calcitonin receptor-like receptor (CLR) and receptor activity-modifying protein 1 (RAMP1) in human gastrointestinal tract.

Authors:  Graeme S Cottrell; Farzad Alemi; Jacob G Kirkland; Eileen F Grady; Carlos U Corvera; Aditi Bhargava
Journal:  Peptides       Date:  2012-03-30       Impact factor: 3.750

10.  Effect of TU-100, a traditional Japanese medicine, administered after hepatic resection in patients with liver cancer: a multi-center, phase III trial (JFMC40-1001).

Authors:  Mitsuo Shimada; Yuji Morine; Hiroaki Nagano; Etsuro Hatano; Takashi Kaiho; Masaru Miyazaki; Toru Kono; Toshiya Kamiyama; Satoshi Morita; Junichi Sakamoto; Mitsuo Kusano; Shigetoyo Saji; Takashi Kanematsu; Masaki Kitajima
Journal:  Int J Clin Oncol       Date:  2014-03-06       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.